Clinical Trials Browser

Unknown × talimogene laherparepvec × Clear all

NCT04065152 2022-06-10

KAPVEC

Phase 2 Unknown

Sarcoma, Kaposi

NCT03747744 2020-12-29

myDCTV

Phase 1 Unknown

Melanoma

NCT03088176 2020-10-12

Combining Talimogene Laherparepvec With BRAF and MEK Inhibitors in BRAF Mutated Advanced Melanoma

Phase 1 Unknown

Melanoma